[go: up one dir, main page]

MX2018009231A - Compuesto novedoso de acido bisfosfonico. - Google Patents

Compuesto novedoso de acido bisfosfonico.

Info

Publication number
MX2018009231A
MX2018009231A MX2018009231A MX2018009231A MX2018009231A MX 2018009231 A MX2018009231 A MX 2018009231A MX 2018009231 A MX2018009231 A MX 2018009231A MX 2018009231 A MX2018009231 A MX 2018009231A MX 2018009231 A MX2018009231 A MX 2018009231A
Authority
MX
Mexico
Prior art keywords
group
acid compound
bisphosphonic acid
salt
atom
Prior art date
Application number
MX2018009231A
Other languages
English (en)
Inventor
Matsumoto Koji
Kobashi Seiichi
Aoyagi Yoshinobu
Kato Hiroshige
Tokuyama Ryuko
Ashizawa Naoki
Ishida Koichi
Original Assignee
Fujiyakuhin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujiyakuhin Co Ltd filed Critical Fujiyakuhin Co Ltd
Publication of MX2018009231A publication Critical patent/MX2018009231A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/386Polyphosphonic acids containing hydroxy substituents in the hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3843Polyphosphonic acids containing no further substituents than -PO3H2 groups
    • C07F9/3852Cycloaliphatic derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3856Polyphosphonic acids containing halogen or nitro(so) substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3865Polyphosphonic acids containing sulfur substituents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se pretende proporcionar un compuesto novedoso de ácido bisfosfónico o una sal del mismo que muestre un efecto inhibidor notable en la calcificación ectópica, y una composición farmacéutica que comprenda el mismo; la presente invención proporciona un compuesto de ácido bisfosfónico representado por la siguiente fórmula (1) o una sal farmacéuticamente aceptable del mismo: (ver formula) en donde ------ representa un enlace sencillo o un doble enlace; A representa un hidrocarburo cíclico saturado o un anillo heterocíclico saturado que comprende un átomo de azufre o un átomo de oxígeno; y R1 y R2 cada uno independientemente representa un grupo alquilo, un grupo alquenilo, un grupo alquinilo, un grupo alcoxi, un grupo ariloxi, un grupo haloalcoxi, un grupo haloalquilo, un átomo de halógeno o un átomo de hidrógeno.
MX2018009231A 2016-01-29 2017-01-27 Compuesto novedoso de acido bisfosfonico. MX2018009231A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016027405 2016-01-29
PCT/JP2017/002855 WO2017131127A1 (ja) 2016-01-29 2017-01-27 新規ビスホスホン酸化合物

Publications (1)

Publication Number Publication Date
MX2018009231A true MX2018009231A (es) 2018-11-09

Family

ID=59398507

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018009231A MX2018009231A (es) 2016-01-29 2017-01-27 Compuesto novedoso de acido bisfosfonico.

Country Status (18)

Country Link
US (1) US10689408B2 (es)
EP (1) EP3409679A4 (es)
JP (1) JP6259957B2 (es)
KR (1) KR20180111791A (es)
CN (1) CN108473518B (es)
AR (1) AR107472A1 (es)
AU (1) AU2017211464B9 (es)
BR (1) BR112018015552A2 (es)
CA (1) CA3012957A1 (es)
CO (1) CO2018007788A2 (es)
MX (1) MX2018009231A (es)
MY (1) MY195906A (es)
PH (1) PH12018501586A1 (es)
RU (1) RU2731615C2 (es)
SG (1) SG11201806125UA (es)
TW (1) TWI730039B (es)
WO (1) WO2017131127A1 (es)
ZA (1) ZA201804945B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102683836B1 (ko) 2018-10-11 2024-07-09 사니핏 테라퓨틱스 에스.에이. 이소성 석회화의 치료를 위한 이노시톨 포스페이트
EP4015494A1 (en) 2020-12-15 2022-06-22 Sanifit Therapeutics S.A. Processes for the preparation of soluble salts of inositol phosphates

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3540150A1 (de) 1985-11-13 1987-05-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DD298267A5 (de) 1989-01-27 1992-02-13 Zentralinstitut Fuer Molekularbiologie,De Verfahren zur immobilisierung von lipase, beta-galactosidase oder invertase
FI89366C (fi) 1990-12-20 1993-09-27 Leiras Oy Foerfarande foer framstaellning av nya farmakologiskt anvaendbara metylenbisfosfonsyraderivat
FI89364C (fi) 1990-12-20 1993-09-27 Leiras Oy Foerfarande foer framstaellning av nya, farmakologiskt anvaendbara metylenbisfosfonsyraderivat
NZ253524A (en) * 1992-05-29 1997-01-29 Procter & Gamble Pharma Sulphur-containing phosphonate derivatives and medicaments (for treating abnormal calcium and phosphate metabolism)
DE69316013T2 (de) * 1992-06-30 1998-07-09 Procter & Gamble Pharma Verwendung von phosphinate zur behandlung der osteoporose
WO2001049295A1 (en) 2000-01-04 2001-07-12 The Regents Of The University Of California Use of low dosage bisphosphonates to inhibit cardiac and arterial calcification
CA2502284A1 (en) 2002-10-15 2004-04-29 Novartis Ag Bisphosphonates for the treatment of antheroscleorosis and devices comprising them
CN1705486A (zh) * 2002-10-15 2005-12-07 诺瓦提斯公司 用于治疗动脉粥样硬化的双膦酸类化合物和包含它们的装置
US7687482B2 (en) * 2006-03-17 2010-03-30 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods
US8012949B2 (en) 2004-10-08 2011-09-06 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS
FR2926080B1 (fr) * 2008-01-03 2010-04-02 Univ Nantes Procede de synthese de derives d'acide hydroxy-bisphosphonique

Also Published As

Publication number Publication date
TWI730039B (zh) 2021-06-11
ZA201804945B (en) 2019-09-25
RU2018130994A (ru) 2020-03-03
CA3012957A1 (en) 2017-08-03
TW201728332A (zh) 2017-08-16
EP3409679A1 (en) 2018-12-05
RU2731615C2 (ru) 2020-09-07
BR112018015552A2 (pt) 2018-12-26
WO2017131127A1 (ja) 2017-08-03
PH12018501586A1 (en) 2019-04-08
SG11201806125UA (en) 2018-08-30
CO2018007788A2 (es) 2018-08-10
AR107472A1 (es) 2018-05-02
EP3409679A4 (en) 2019-11-06
AU2017211464B9 (en) 2021-07-22
CN108473518A (zh) 2018-08-31
HK1257616A1 (zh) 2019-10-25
JPWO2017131127A1 (ja) 2018-02-01
CN108473518B (zh) 2021-07-06
AU2017211464A1 (en) 2018-08-09
MY195906A (en) 2023-02-27
RU2018130994A3 (es) 2020-03-13
US10689408B2 (en) 2020-06-23
US20190002482A1 (en) 2019-01-03
AU2017211464B2 (en) 2021-07-01
JP6259957B2 (ja) 2018-01-10
KR20180111791A (ko) 2018-10-11

Similar Documents

Publication Publication Date Title
PH12014502211A1 (en) Alkyl phenyl sulfide derivative and pest control agent
PH12016501822A1 (en) Cyclopropaneamine compound
ZA202206923B (en) New methylquinazolinone derivatives
AR090292A1 (es) Compuestos basados en pirazolo[1,5-a]pirimidina, composiciones que los comprenden y metodos que los utilizan
PH12016501813A1 (en) 1,3-benzodioxole derivative
MX2009010024A (es) Nuevo compuesto de adenina.
MX2009010071A (es) Derivados de aril isoxazolina insecticidas.
PH12014500475A1 (en) Agricultural and horticultural fungicidal composition
IN2014DN10806A (es)
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
GEP201606555B (en) Compounds and compositions for modulating egfr activity
MX2012007060A (es) Compuesto heterociclico conteniendo nitrogeno y fungicida para el uso en agricultura y jardineria.
MY169043A (en) New dihydroquinoline-2-one derivatives
MY177250A (en) Novel nicotinamide derivative or salt thereof
JO3261B1 (ar) مشتق بيريدين أحادي الحلقة
MX2016006685A (es) Compuestos heterociclicos de n-acilimino.
MY161134A (en) Piperazine compound having a pgds inhibitory effect
PH12015502429A1 (en) Dicarboxylic acid compound
UA112556C2 (uk) Інсектицидні похідні 2-метоксибензамідів
PH12019502868A1 (en) Composition for injection
TN2014000519A1 (en) Pyrimidinone derivatives as antimalarial agents
MX2016006763A (es) Inhibidores de tirosina cinasa de bruton.
MY185558A (en) Pyrido-oxazinone derivatives as tnap inhibitors
PH12018501586A1 (en) Novel biphosphonic acid compound
MY152557A (en) 3-aminocyclopentanecarboxamides as chemokine receptor modulators